Patients' existing non-steroidal anti-inflammatory drug (NSAID) at approved doses ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	3

46. Malignant rheumatoid arthritis

Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2007-000012-90-NL (EUCTR)	01/06/2011	18/10/2010	The Standard care versus Celecoxib Outcome Trial (SCOT): A Large Streamlined Safety Study - SCOT Tri ...	The Standard care versus Celecoxib Outcome Trial (SCOT): A Large Streamlined Safety Study - SCOT Tri ...	The Standard Care versus Celecoxib Outcome Trial (SCOT) is a large streamlined safety study designed ...	Trade Name: Celebrex Trade Name: Patients' existing non-steroidal anti-inflammatory drug (NSAID) at a ...	University of Dundee	NULL	Not Recruiting			Female: yes Male: yes			Denmark;Netherlands;United Kingdom
2	EUCTR2007-000012-90-GB (EUCTR)	23/01/2008	28/03/2007	The Standard care versus Celecoxib Outcome Trial (SCOT): A Large Streamlined Safety Study - SCOT Tri ...	The Standard care versus Celecoxib Outcome Trial (SCOT): A Large Streamlined Safety Study - SCOT Tri ...	The Standard Care versus Celecoxib Outcome Trial (SCOT) is a large streamlined safety study designed ...	Trade Name: Celebrex Trade Name: Patients' existing non-steroidal anti-inflammatory drug (NSAID) at a ...	University of Dundee	NULL	Not Recruiting			Female: yes Male: yes		Phase 4	Denmark;Netherlands;United Kingdom
3	EUCTR2007-000012-90-DK (EUCTR)	02/11/2007	25/09/2007	The Standard care versus Celecoxib Outcome Trial (SCOT): A Large Streamlined Safety StudyDansk:Klini ...	The Standard care versus Celecoxib Outcome Trial (SCOT): A Large Streamlined Safety StudyDansk:Klini ...	The Standard Care versus Celecoxib Outcome Trial (SCOT) is a large streamlined safety study designed ...	Trade Name: Celebra (celecoxib) INN or Proposed INN: CELECOXIB Trade Name: Patients' existing non-ster ...	University of Dundee	NULL	Not Recruiting			Female: yes Male: yes	13682	Phase 4	Denmark;Netherlands;United Kingdom

First Previous1Next Last